These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33493256)

  • 1. Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design.
    Bonaca MP; George RT; Morrow DA; Bergmark BA; Park JG; Abuhatzira L; Vavere AL; Karathanasis SK; Jin C; She D; Hirshberg B; Hsia J; Sabatine MS
    Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):243-252. PubMed ID: 33493256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
    Bonaca MP; Morrow DA; Bergmark BA; Berg DD; Lima JAC; Hoffmann U; Kato Y; Lu MT; Kuder J; Murphy SA; Spinar J; Oude Ophuis T; Kiss RG; Lopez-Sendon J; Averkov O; Wheatcroft SB; Kubica J; Carlos Nicolau J; Furtado RHM; Abuhatzira L; Hirshberg B; Omar SA; Vavere AL; Chang YT; George RT; Sabatine MS
    Circulation; 2022 Sep; 146(12):907-916. PubMed ID: 36039762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport.
    George RT; Abuhatzira L; Stoughton SM; Karathanasis SK; She D; Jin C; Buss NAPS; Bakker-Arkema R; Ongstad EL; Koren M; Hirshberg B
    J Am Heart Assoc; 2021 Jul; 10(13):e014572. PubMed ID: 34121413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys.
    Thornburg JT; Parks JS; Rudel LL
    J Lipid Res; 1995 Feb; 36(2):277-89. PubMed ID: 7751815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of plasma lecithin:cholesterol acyltransferase in man. III. Role of high density lipoprotein cholesteryl esters in the activating effect of a high-fat test meal.
    Rose HG; Juliano J
    J Lipid Res; 1979 Mar; 20(3):399-407. PubMed ID: 221605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin-Cholesterol Acyltransferase Autoantibody.
    Komatsu T; Katsurada Y; Miyashita K; Abe S; Nishida T; Endo Y; Teramoto M; Sasaki K; Arakawa J; Sasaki M; Suzuki N; Kuwata K; Imakiire T; Miyake T; Sakurada M; Matsukuma S; Hirano T; Uehara Y; Ikewaki K
    J Atheroscler Thromb; 2023 Aug; 30(8):1070-1082. PubMed ID: 36384970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
    Ossoli A; Simonelli S; Varrenti M; Morici N; Oliva F; Stucchi M; Gomaraschi M; Strazzella A; Arnaboldi L; Thomas MJ; Sorci-Thomas MG; Corsini A; Veglia F; Franceschini G; Karathanasis SK; Calabresi L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):915-924. PubMed ID: 30894011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
    Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT Activator.
    Vitali C; Cuchel M
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):377-379. PubMed ID: 33356367
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
    Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
    J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.
    Sparks DL; Anantharamaiah GM; Segrest JP; Phillips MC
    J Biol Chem; 1995 Mar; 270(10):5151-7. PubMed ID: 7890624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.